Olumiant สหภาพยุโรป - โรมาเนีย - EMA (European Medicines Agency)

olumiant

eli lilly nederland b.v. - baricitinib - artrita, reumatoida - imunosupresoare - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant poate fi utilizat ca monoterapie sau în asociere cu metotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Cibinqo สหภาพยุโรป - โรมาเนีย - EMA (European Medicines Agency)

cibinqo

pfizer europe ma eeig  - abrocitinib - dermatita, atopică - alte preparate dermatologice - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

OLUMIANT 2 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

olumiant 2 mg

lilly s.a. - spania - baricitinibum - compr. film. - 2mg - imunosupresoare imunosupresoare selective

OLUMIANT 4 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

olumiant 4 mg

lilly s.a. - spania - baricitinibum - compr. film. - 4mg - imunosupresoare imunosupresoare selective

CIBINQO 100 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

cibinqo 100 mg

pfizer manufacturing deutschland gmbh - germania - abrocitinibum - compr. film. - 100mg - preparate de uz dermatologic alte preparate de uz dermatologic

CIBINQO 200 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

cibinqo 200 mg

pfizer manufacturing deutschland gmbh - germania - abrocitinibum - compr. film. - 200mg - preparate de uz dermatologic alte preparate de uz dermatologic

CIBINQO 50 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

cibinqo 50 mg

pfizer manufacturing deutschland gmbh - germania - abrocitinibum - compr. film. - 50mg - preparate de uz dermatologic alte preparate de uz dermatologic

DIFLUCAN 10 mg/ml โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

diflucan 10 mg/ml

fareva amboise - franta - fluconazolum - pulb. pt. susp. orala - 10mg/ml - antimicotice de uz sistemic derivati de triazol

DIFLUCAN 150 mg โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

diflucan 150 mg

fareva amboise - franta - fluconazolum - caps. - 150mg - antimicotice de uz sistemic derivati de triazol

DIFLUCAN 2mg/ml โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

diflucan 2mg/ml

fareva amboise - franta - fluconazolum - sol. perf. - 2mg/ml - antimicotice de uz sistemic derivati de triazol